East Lansing, MI, United States of America

Serban F Peteu

This inventor holds 17 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Ascensia Diabetes Care Holdings Ag, Bayer Healthcare LLC, Michigan State University. Active years: 1997-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Serban F Peteu. Retrieved from https://idiyas.com/inventor/serban-f-peteu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 76.5

 

 

Average Co-Inventor Count = 5.1

ph-index = 4

Forward Citations = 590(Granted Patents)


Company Filing History:


Years Active: 1997-2020

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Innovative Journey of Serban F Peteu

Introduction: Serban F Peteu is a pioneering inventor based in East Lansing, MI, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Serban F Peteu holds several patents in various technological domains, showcasing his versatility and ingenuity in creating novel solutions to complex problems.

Career Highlights: Throughout his illustrious career, Serban F Peteu has consistently pushed the boundaries of innovation, with a focus on developing cutting-edge technologies that have the potential to revolutionize industries.

Collaborations: Serban F Peteu has collaborated with leading research institutions, universities, and companies to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: In conclusion, Serban F Peteu stands as a visionary inventor whose relentless pursuit of innovation continues to inspire and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…